Response From the Editors RE: DUOPA® Is an Excellent Alternative Treatment but With Some Caveats

Bhatia, Kailash P.; Merello, Marcelo

dc.contributor.author	Bhatia, Kailash P.
dc.contributor.author	Merello, Marcelo
dc.date.accessioned	2020-02-05T14:49:17Z
dc.date.available	2020-02-05T14:49:17Z
dc.date.issued	2019-03-27
dc.identifier.citation	Bhatia, K., Merello, M., 2019. Response from the Editors RE: DUOPA® is an Excellent Alternative Treatment but with Some Caveats. Mov Dis. Clin. Pract. 2019 Mar 27;6(4):338. doi: 10.1002/mdc3.12737.	en_US
dc.identifier.uri	https://doi.org/10.1002/mdc3.12737
dc.identifier.uri	https://repositorio.fleni.org.ar/handle/123456789/176
dc.description.abstract	Resumen no disponible
dc.language.iso	eng	en_US
dc.publisher	Wiley	en_US
dc.rights	info:eu-repo/semantics/openAccess
dc.rights.uri	https://creativecommons.org/licenses/by/2.5/ar/
dc.subject	DUOPA	en_US
dc.subject	Levodopa	en_US
dc.subject	Carbidopa	en_US
dc.title	Response From the Editors RE: DUOPA® Is an Excellent Alternative Treatment but With Some Caveats	en_US
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	info:eu-repo/semantics/article	en_US
dc.description.fil	Fil: Bhatia, Kailash P. University College London. Institute of Neurology; Reino Unido.
dc.description.fil	Fil: Merello, Marcelo. Fleni. Departamento de Neurología. Servicio de Movimientos Anormales; Argentina.
dc.relation.ispartofVOLUME	6
dc.relation.ispartofNUMBER	4
dc.relation.ispartofPAGINATION	338
dc.relation.ispartofCOUNTRY	Estados Unidos
dc.relation.ispartofCITY	Hoboken
dc.relation.ispartofTITLE	Movement disorders clinical practice
dc.relation.ispartofISSN	2330-1619
dc.type.snrd	info:ar-repo/semantics/artículo	es_ES